A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy
收藏DataCite Commons2026-01-28 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00009778/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The objective of this study is to evaluate the efficacy and safety of upadacitinib compared
to placebo as induction therapy in participants with moderately and severely active Crohn's
disease (CD).
提供机构：
Vivli
创建时间：
2024-01-23
